- Home
- PDS vs BBNX Comparison
PDS vs BBNX Comparison
Compare PDS & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDS
- BBNX
- Stock Information
- Founded
- PDS 1951
- BBNX 2015
- Country
- PDS Canada
- BBNX United States
- Employees
- PDS N/A
- BBNX N/A
- Industry
- PDS
- BBNX Medical/Dental Instruments
- Sector
- PDS
- BBNX Health Care
- Exchange
- PDS Nasdaq
- BBNX Nasdaq
- Market Cap
- PDS 764.8M
- BBNX 740.7M
- IPO Year
- PDS N/A
- BBNX 2025
- Fundamental
- Price
- PDS $58.06
- BBNX $23.05
- Analyst Decision
- PDS Buy
- BBNX Strong Buy
- Analyst Count
- PDS 2
- BBNX 10
- Target Price
- PDS $87.00
- BBNX $24.40
- AVG Volume (30 Days)
- PDS 75.2K
- BBNX 684.8K
- Earning Date
- PDS 10-28-2025
- BBNX 11-06-2025
- Dividend Yield
- PDS N/A
- BBNX N/A
- EPS Growth
- PDS N/A
- BBNX N/A
- EPS
- PDS 5.22
- BBNX N/A
- Revenue
- PDS $1,355,177,217.00
- BBNX $69,830,000.00
- Revenue This Year
- PDS N/A
- BBNX $42.80
- Revenue Next Year
- PDS $1.37
- BBNX $34.58
- P/E Ratio
- PDS $11.12
- BBNX N/A
- Revenue Growth
- PDS N/A
- BBNX 38911.17
- 52 Week Low
- PDS $36.20
- BBNX $8.89
- 52 Week High
- PDS $67.46
- BBNX $26.66
- Technical
- Relative Strength Index (RSI)
- PDS 58.61
- BBNX 61.97
- Support Level
- PDS $55.85
- BBNX $18.12
- Resistance Level
- PDS $59.36
- BBNX $19.32
- Average True Range (ATR)
- PDS 1.51
- BBNX 1.47
- MACD
- PDS -0.06
- BBNX 0.03
- Stochastic Oscillator
- PDS 70.92
- BBNX 57.73
About PDS Precision Drilling Corporation
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.